Your browser doesn't support javascript.
loading
Osteosynthesis-associated infection of the lower limbs by multidrug-resistant and extensively drug-resistant Gram-negative bacteria: a multicentre cohort study.
Giannitsioti, Efthymia; Salles, Mauro José; Mavrogenis, Andreas; Rodriguez-Pardo, Dolors; Los-Arcos, Ibai; Ribera, Alba; Ariza, Javier; Del Toro, María Dolores; Nguyen, Sophie; Senneville, Eric; Bonnet, Eric; Chan, Monica; Pasticci, Maria Bruna; Petersdorf, Sabine; Benito, Natividad; O' Connell, Nuala; Blanco García, Antonio; Skaliczki, Gábor; Tattevin, Pierre; Kocak Tufan, Zeliha; Pantazis, Nikolaos; Megaloikonomos, Panayiotis D; Papagelopoulos, Panayiotis; Soriano, Alejandro; Papadopoulos, Antonios.
Afiliación
  • Giannitsioti E; Fourth Department of Internal Medicine, University General Hospital Attikon, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Salles MJ; Division of Infectious Diseases, Department of Internal Medicine, Escola Paulista de Medicina, Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil.
  • Mavrogenis A; First Department of Orthopaedics, University General Hospital Attikon, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Rodriguez-Pardo D; Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Los-Arcos I; Department of Infectious Diseases, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
  • Ribera A; Department of Infectious Diseases, Hospital Universitari Bellvitge, Barcelona, Spain.
  • Ariza J; Department of Infectious Diseases, Hospital Universitari Bellvitge, Barcelona, Spain.
  • Del Toro MD; Infectious Diseases Unit, Hospital Universitario Virgen Macarena, Instituto de Biomedicina de Sevilla (IBIS), Universidad de Sevilla, Seville, Spain.
  • Nguyen S; Infectious Diseases Department, Gustave Dron Hospital, Tourcoing, France.
  • Senneville E; Infectious Diseases Department, Gustave Dron Hospital, Tourcoing, France.
  • Bonnet E; Department of Infectious Diseases, Clinique Pasteur, Toulouse, France.
  • Chan M; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.
  • Pasticci MB; Infectious Diseases Unit, University of Perugia, Perugia, Italy.
  • Petersdorf S; Institute for Medical Laboratory Diagnostics, Helios University Clinic Wuppertal, Wuppertal, Germany.
  • Benito N; Infectious Diseases Unit, Hospital de la Santa Creu i Sant Pau, Institut d'Investigació Biomèdica Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • O' Connell N; Department of Clinical Microbiology, University Hospital Limerick, Limerick, Ireland.
  • Blanco García A; Bone and Joint Infection Unit, Department of Emergency Medicine, IIS-Fundación Jiménez Díaz Hospital, Madrid, Spain.
  • Skaliczki G; Department of Orthopaedics, Semmelweis University, Budapest, Hungary.
  • Tattevin P; Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
  • Kocak Tufan Z; Department of Infectious Diseases and Clinical Microbiology, Faculty of Medicine, Yildirim Beyazit University, Ankara Atatürk Education and Research Hospital, Ankara, Turkey.
  • Pantazis N; Department of Hygiene, Epidemiology and Medical Statistics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Megaloikonomos PD; First Department of Orthopaedics, University General Hospital Attikon, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Papagelopoulos P; First Department of Orthopaedics, University General Hospital Attikon, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • Soriano A; Department of Infectious Diseases, Hospital Clínic, Barcelona, University of Barcelona, IDIBAPS, Barcelona, Spain.
  • Papadopoulos A; Fourth Department of Internal Medicine, University General Hospital Attikon, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
  • The Esgiai Collaborators Study Group; A full list of authors appears at the end of the paper.
J Bone Jt Infect ; 7(6): 279-288, 2022.
Article en En | MEDLINE | ID: mdl-36644590
ABSTRACT

Purpose:

The purpose of this study was the clinical and therapeutic assessment of lower-limb osteosynthesis-associated infection (OAI) by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB), which have been poorly studied to date.

Methods:

A prospective multicentre observational study was conducted on behalf of ESGIAI (the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group on Implant-Associated Infections). Factors associated with remission of the infection were evaluated by multivariate and Cox regression analysis for a 24-month follow-up period.

Results:

Patients ( n = 57 ) had a history of trauma (87.7 %), tumour resection (7 %) and other bone lesions (5.3 %). Pathogens included Escherichia coli ( n = 16 ), Pseudomonas aeruginosa ( n = 14 ; XDR 50 %), Klebsiella spp. ( n = 7 ), Enterobacter spp. ( n = 9 ), Acinetobacter spp. ( n = 5 ), Proteus mirabilis ( n = 3 ), Serratia marcescens ( n = 2 ) and Stenotrophomonas maltophilia ( n = 1 ). The prevalence of ESBL (extended-spectrum ß -lactamase), fluoroquinolone and carbapenem resistance were 71.9 %, 59.6 % and 17.5 % respectively. Most patients ( n = 37 ; 64.9 %) were treated with a combination including carbapenems ( n = 32 ) and colistin ( n = 11 ) for a mean of 63.3 d. Implant retention with debridement occurred in early OAI (66.7 %), whereas the infected device was removed in late OAI (70.4 %) ( p = 0.008 ). OAI remission was achieved in 29 cases (50.9 %). The type of surgery, antimicrobial resistance and duration of treatment did not significantly influence the outcome. Independent predictors of the failure to eradicate OAI were age > 60  years (hazard ratio, HR, of 3.875; 95 % confidence interval, CI95 %, of 1.540-9.752; p = 0.004 ) and multiple surgeries for OAI (HR of 2.822; CI95 % of 1.144-6.963; p = 0.024 ).

Conclusions:

Only half of the MDR/XDR GNB OAI cases treated by antimicrobials and surgery had a successful outcome. Advanced age and multiple surgeries hampered the eradication of OAI. Optimal therapeutic options remain a challenge.

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Bone Jt Infect Año: 2022 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Bone Jt Infect Año: 2022 Tipo del documento: Article País de afiliación: Grecia